is there still a glp-1 shortage The drug over. What's next for the compounders? - Pharma Technology Focus | Issue 154 FDA says shortage of GLP-1

Description

Group, Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study, Diabetes care, 35 (2012) 252258

These mimic the actions of the hormone GLP-1 (short for glucagon-like peptide-1 receptors), which regulates blood sugar levels by stimulating insulin release

Obesity is a chronic disease, so we have to treat it as such, Dr

Find out at Obesity: A Worldwide Pandemic with Advancing Management Options . Novo Nordisk: The Pioneer in GLP-1 Therapy Novo Nordisk, the pharmaceutical giant, revolutionized weight loss treatment by pioneering GLP-1 receptor agonists